XTAI
1325
Market cap81mUSD
Oct 08, Last price
30.55TWD
1D
9.89%
1Q
24.95%
Jan 2017
45.13%
Name
Universal Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Universal Incorporation, together with its subsidiaries, manufactures and sells nonwoven fabrics and its related products in Taiwan, the United States, Northeast Asia, and China. It offers SMMS and SMS fabrics for use in the hygiene, medical, and industrial markets; spun bond fabrics that are used in the hygiene, medical, industrial, and agricultural markets; and melt-blown fabrics for use in filtration, insulators, and absorbents. The company also provides HEPA filter media products for air purifier, air conditioner, and clean room; cabin air filter media products; composite filter media products for anti-bacteria and VOCs removal; respirator and face mask filter media products; recycled PP resin products; medical face, surgical, and medical activated carbon mask products; and medical D2 respirator and protective surgical respirator face mask products. In addition, it offers in-line and post-treatment products; and outsourcing services, such as non-woven and film laminations, ultrasonic bonding, coatings, and printings. Universal Incorporation was incorporated in 1962 and is based in Taipei, Taiwan.
Key people
Meihui Huang
Chairman of the Board, General Manager · since 2011
Qinghai Gao
Deputy General Manager, Director · since 2020
Shuji Liao
Head of Accounting, Corporate Governance Officer · since 2023
Shoulu Zhou
Chief Information Security Officer · since 2025
Mingxiong Huang
Director · since 2002
Hua Lin
Director · since 2011
Zhengming Wu
Independent Director · since 2017
Minglun Zang
Independent Director · since 2020
Jinlian Zhang
Independent Director · since 2017
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||